Screener
Ormat Technologies ORA Redeemable NCI
Redeemable NCI at other companies
Other financials
Where this comes from
Reported directly by Ormat Technologies in its filing.
Tagged under the XBRL concept us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount.
The source filing: Ormat Technologies’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 1:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001296445-26-000014
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Other long-term liabilities | 29,054 | 33,637 |
| Total liabilities | 4,044,260 | 3,555,232 |
| Commitments and contingencies (Note 9) | ||
| Redeemable noncontrolling interest | 9,906 | 10,402 |
| Equity: | ||
| The Company's stockholders' equity: | ||
| Common stock, par value $0.001 per share; 200,000,000 shares authorized; 61,980,201 and 61,104,078 shares issued; 61,496,941 and 60,845,411 shares outstanding, respectively | 62 | 61 |
| Additional paid-in capital | 1,672,309 | 1,654,635 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ormat Technologies's redeemable NCI?
- Ormat Technologies (ORA) reported redeemable NCI of $9.91M in Q2 2026.
- How has Ormat Technologies's redeemable NCI changed year-over-year?
- Ormat Technologies's redeemable NCI decreased by 9.8% year-over-year, from $10.99M to $9.91M.
- What is the long-term trend for Ormat Technologies's redeemable NCI?
- Over 5 years (2020 to 2025), Ormat Technologies's redeemable NCI has grown at a 1.1% compound annual growth rate (CAGR), from $9.83M to $10.4M.
- What does redeemable NCI mean?
- Minority interests in subsidiaries that include a put option allowing the minority holder to require the parent to repurchase their stake.
Ask your AI about Ormat Technologies's redeemable nci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude